Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Akari Therapeutics’ Nomacopan Granted U.S. Orphan Drug Designation for Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy (HSCT-TMA)

Saturday, August 31, 2019

Akari Therapeutics Plc a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where the complement C andor leukotriene LTB systems are implicated today announced that the US Food and Drug...

Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies

Friday, August 30, 2019

Novartis a global leader in neuroscience today announced positive results for ofatumumab OMB from the Phase III ASCLEPIOS I and II studies In both headtohead studies ofatumumab demonstrated superiority over Aubagio teriflunomide in patients with rela...

SpringWorks Therapeutics Receives Breakthrough Therapy Designation for Nirogacestat for the Treatment of Adult Patients with Progressive, Unresectable, Recurrent or Refractory Desmoid Tumors

Friday, August 30, 2019

SpringWorks Therapeutics Inc a clinicalstage biopharmaceutical company focused on developing lifechanging medicines for patients with severe rare diseases and cancer today announced the US Food and Drug Administration FDA has granted Breakthrough The...

Phillips-Medisize Highlights Innovations in Drug Delivery and Digital Health at Suzhou Dialogue 2019 in China on September 1-3

Thursday, August 29, 2019

PhillipsMedisize a Molex company announces a significant exhibiting and speaking presence at the Suzhou Dialogue conference organized by the China National Pharmaceutical Packaging Association CNPAA and to be held from September to in Suzhou Industr...

FDA Accepts SHINKEI Therapeutics Investigational New Drug Application for MR-301 for Traumatic Brain Injury

Thursday, August 29, 2019

SHINKEI Therapeutics a clinical stage pharmaceutical company focused on the development of therapeutic drugs for the treatment of Central Nervous System CNS disorders today announced that they received notification from Food and Drug Administration F...

Esco Ventures Announces the Launch of Carmine Therapeutics, a Company Pioneering Red Blood Cell (RBC)-Derived Extracellular Vesicle (EV)-Based Gene Therapies

Thursday, August 29, 2019

Esco Ventures is pleased to announce the launch of Carmine Therapeutics and execution of an exclusive license agreement for the technology developed in the laboratories of Professors Minh Le and Jiahai Shi at the City University of Hong Kong Carmine...

Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products expressing IL-7 and CCL19 as a next-generation treatment for cancer patients

Wednesday, August 28, 2019

Adaptimmune Therapeutics plc a leader in Tcell therapy to treat cancer and NoileImmune Biotech Inc Tokyo Japan a biotechnology company focusing on the development of innovative cancer immunotherapies today announced that they will codevelop nextgener...

Sigilon Therapeutics Receives Orphan Drug Designation for SIG-001 for the Treatment of Hemophilia A

Wednesday, August 28, 2019

Sigilon Therapeutics today announced it has received Orphan Drug Designation for SIG an investigational therapy for hemophilia A that leverages Sigilons Shielded Living Therapeutics platform to implant cells engineered to produce stable blood plasma...

Velabs Therapeutics Enters into a Screening Cooperation with Chiome Bioscience in the Field of GPCR-Specific Functional Antibody Screening After Successful Feasibility Study

Tuesday, August 27, 2019

Velabs Therapeutics specializing in the fast generation of functional therapeutic antibodies today announced that its cooperation with Chiome Bioscience Inc Tokyo will be deepened to jointly discover modulatory and functional antibodies for one of Ch...

Rentschler Fill Solutions receives open-ended GMP certification by the Austrian authority AGES

Tuesday, August 27, 2019

Rentschler Fill Solutions GmbH a contract development and manufacturing organization CDMO and expert for aseptic filling and finishing of biopharmaceuticals received notification from the Austrian Agency for Health and Food Safety